1 - 10 of 428 Results
Condition Status ˆ Requirements ˇ Location Near You ˇ
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

205888-Attachment Inhibitor comparison in Heavily Treatment Experienced patients
205888-Attachment Inhibitor comparison in Heavily Treatment Experienced patients
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

208569-Use and effectiveness of dolutegravir-based regimens in naïve and virologically suppressed ART-experienced individuals from the Cohort of the Spanish AIDS Research Network (CoRIS)
208569-Use and effectiveness of dolutegravir-based regimens in naïve and virologically suppressed ART-experienced individuals from the Cohort of the Spanish AIDS Research Network (CoRIS)
Human Immunodeficiency Virus (HIV)
Recruiting
18+

To find a center near you, please provide a Country or Postal Code.

208982-Dolutegravir/Rilpivirine, antiretroviral efficacy study using real-world data in subjects with human immunodeficiency virus (HIV)-1
208982-Dolutegravir/Rilpivirine, antiretroviral efficacy study using real-world data in subjects with human immunodeficiency virus (HIV)-1
Human Immunodeficiency Virus (HIV)
Recruiting
12+

To find a center near you, please provide a Country or Postal Code.

204666-An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of Tivicay administered in Korean subjects for treatment of HIV-1 infection in real life practice
204666-An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of Tivicay administered in Korean subjects for treatment of HIV-1 infection in real life practice
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

A4001067-Prospective Observational Epidemiologic Study of Maraviroc's Safety
A4001067-Prospective Observational Epidemiologic Study of Maraviroc's Safety
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

209035-Phase 2b, open-label, multicenter, rollover study to assess antiviral activity and safety of Long-acting Cabotegravir (CAB LA) plus Long-acting Rilpivirine (RPV LA), administered every 2 months (Q2M), in human immunodeficiency virus (HIV)- positive subjects from the LATTE study
209035-Phase 2b, open-label, multicenter, rollover study to assess antiviral activity and safety of Long-acting Cabotegravir (CAB LA) plus Long-acting Rilpivirine (RPV LA), administered every 2 months (Q2M), in human immunodeficiency virus (HIV)- positive subjects from the LATTE study
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

201585-Study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus long-acting rilpivirine from current antiretroviral regimen in virologically suppressed HIV-1-infected adults
201585-Study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus long-acting rilpivirine from current antiretroviral regimen in virologically suppressed HIV-1-infected adults
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

205543-An efficacy, safety, and tolerability study comparing dolutegravir (DTG) plus lamivudine (3TC) with dolutegravir plus tenofovir/emtricitabine in treatment naïve HIV infected subjects (Gemini 2)
205543-An efficacy, safety, and tolerability study comparing dolutegravir (DTG) plus lamivudine (3TC) with dolutegravir plus tenofovir/emtricitabine in treatment naïve HIV infected subjects (Gemini 2)
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

111762-A Study of GSK1349572 versus Raltegravir (RAL) with Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
111762-A Study of GSK1349572 versus Raltegravir (RAL) with Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Human Immunodeficiency Virus (HIV)
Recruiting
12-99

To find a center near you, please provide a Country or Postal Code.

114916-Dolutegravir Expanded Access Study
114916-Dolutegravir Expanded Access Study